Sign Petition

Right to treatment

31 Signatures Goal: 100

Pfizer have developed a new treatment for diabetics - Exubera, an insulin which can be inhaled. The greatest potential advance in treatment for 80 years which could transform the lives of diabetics but it has been rejected by NICE on grounds of cost. However, it's benefits are huge. Not only will it bring an end to injections, for some up to five a day; but it will also reduce complications such as heart disease, amputation, blindness and kidney failure. Therefore, please show your support in asking NICE to reconsider its decision and to look at the overall benefits which would ultimately reduce lifecycle costs whilst improving the lives of millions.

Comment

22

Signatures

  • 7 years ago
    Peter Yates United Kingdom
    7 years ago
  • 7 years ago
    Lynne United Kingdom
    7 years ago
  • 7 years ago
    Ben United Kingdom
    7 years ago
  • 7 years ago
    J Butler United Kingdom
    7 years ago
  • 7 years ago
    Carl United Kingdom
    7 years ago
  • 8 years ago
    Travis Cooper Australia
    8 years ago
  • 8 years ago
    Debbie Brookes United Kingdom
    8 years ago
  • 8 years ago
    Emma United Kingdom
    8 years ago
  • 8 years ago
    Mike Wenden Netherlands
    8 years ago
  • 8 years ago
    Gillian Nash United States
    8 years ago
  • 8 years ago
    roy osborne United Kingdom
    8 years ago
  • 8 years ago
    Grahame Smith United Kingdom
    8 years ago
  • 8 years ago
    Loffroy France
    8 years ago
  • 8 years ago
    Ian Garman United Kingdom
    8 years ago
  • 8 years ago
    Tracey Langridge United Kingdom
    8 years ago
See More